Merck & Co., Inc. (MRK)

106.78 +0.33 (+0.31%) USD  |  NYSE  |  Dec 26, 16:00
106.90 +0.12 (+0.11%) After-Hours: 20:00
More

Merck Construction in Progress (Quarterly)

Construction in Progress (Quarterly) Chart

View Construction in Progress (Quarterly) for MRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Construction in Progress (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Construction in Progress Definition

View Construction in Progress Definition
Start Trial

Construction in Progress is a long-term asset that records the costs associated directly with the building of an asset.

Read full definition.

Construction in Progress (Quarterly) Range, Past 5 Years

View Construction in Progress (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Construction in Progress (Quarterly) Benchmarks

View Construction in Progress (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Biogen, Inc. --
Regeneron Pharmaceuticals, Inc. --
Cidara Therapeutics, Inc. --
Moderna, Inc. Upgrade